Given that these outcomes occurred in miR-146b−/− mice, we hypothesize that miR-146b deficiency-mediated polarization of TAMs promotes tumor progression, whereas increased PD-L1 expression potentially drives a response to anti-PD1 immunotherapy. Here, PDCD1 is linked to neoplasm.